Skip Navigation
Skip to contents

ICoLA 2021

Today : 2021.04.21
D- 142
Please fill out the following form to contact
the ICoLA 2021 secretariat.
contact us

닫기

Scientific Program

  • HOME
  • Program
  • Scientific Program

BREAKFAST SYMPOSIUM 1
Sep.10(Fri.)
08:00 - 09:00
Room 1
BREAKFAST SYMPOSIUM 2
Sep.10(Fri.)
08:00 - 09:00
Room 2
BREAKFAST SYMPOSIUM 3
Sep.10(Fri.)
08:00 - 09:00
Room 3
PLENARY LECTURE 1
Sep.10(Fri.)
09:00 - 09:30
Room 1+2+3
What's new in epidemiology of ASCVD & risk factors Raul Santos (University of São Paulo, Brazil)
BREAK
Sep.10(Fri.)
09:30 - 09:40
All
SYMPOSIUM 1 Emerging risk factors for atherosclerosis
Sep.10(Fri.)
09:40 - 11:15
Room 1
09:40-10:03 NAFLD, NASH & cardiovascular disease Masahiro Koseki (Osaka University, Japan)
10:03-10:26 Blood cells & bone marrow in atherosclerosis Marit Westerterp (University of Groningen, Netherlands)
10:26-10:49 Heterogeneity of NAFLD from the perspective of atherosclerosis Bo Kyung Koo (Seoul National University, Korea)
10:49-11:15 Discussion
SYMPOSIUM 2 Risk assessment for primary prevention
Sep.10(Fri.)
09:40 - 11:15
Room 2
09:40-10:03 Integration of new imaging or biomarkers to risk calculators
10:03-10:26 Understanding cardiovascular risk: using risk scores and other risk-based testing in the contemporary era Ian Neeland (University Hospitals Cleveland Medical Center, USA)
10:26-10:49 Risk model for CV risk assessment in Korean population Seung-Hwan Lee (The Catholic University of Korea, Korea)
10:49-11:15 Discussion
SYMPOSIUM 3 Clinical implication of genetic/epigenetic studies on coronary artery disease & dyslipidemia
Sep.10(Fri.)
09:40 - 11:15
Room 3
09:40-10:03 Mapping genetic associations to novel therapeutics for cardiometabolic disease Pradeep Natarajan (Harvard Medical School, USA)
10:03-10:26 Clinical implication of recent epigenetic studies on CAD & dyslipidemia Sung Ho Park (UNIST, Korea)
10:26-10:49 How can we derive biological relevance from genetic studies on atherosclerosis? Mete Civelek (University of Virginia, USA)
10:49-11:15 Discussion
SYMPOSIUM 4 Immune cells in blood vessels
Sep.10(Fri.)
09:40 - 11:15
Room 4
09:40-10:03 Myeloid cell heterogeneity in atherosclerosis Jae Hoon Choi (Hanyang University, Korea)
10:03-10:26 CD8+ T cells in atherosclerosis
10:26-10:49 Role of lymphocytes in atherosclerosis
10:49-11:15 Discussion
SYMPOSIUM 5 New look at smooth muscle cells in atherosclerosis
Sep.10(Fri.)
09:40 - 11:15
Room 5
09:40-10:03 Cellular plasticity in atherosclerosis Judith Sluimer (Maastricht University, Netherlands)
10:03-10:26 New mechanism of vascular calcification Byeong Hwa Jeon (Chungnam National University, Korea)
10:26-10:49 Phenotypic changes of VSMC in atherosclerosis Chang Seon Myung (Chungnam National University, Korea)
10:49-11:15 Discussion
COFFEE BREAK
Sep.10(Fri.)
11:15 - 11:25
All
OPENING ADDRESS
Sep.10(Fri.)
11:25 - 11:35
All
PLENARY LECTURE 2
Sep.10(Fri.)
11:35 - 12:05
Room 1+2+3
Single cell RNA and antibody sequencing in women and men with cardiovascular disease Klaus Ley (La Jolla Institute for Immunology, USA)
LUNCHEON SYMPOSIUM 1
Sep.10(Fri.)
12:05 - 13:05
Room 1
LUNCHEON SYMPOSIUM 2
Sep.10(Fri.)
12:05 - 13:05
Room 2
LUNCHEON SYMPOSIUM 3
Sep.10(Fri.)
12:05 - 13:05
Room 3
LUNCHEON SYMPOSIUM 4
Sep.10(Fri.)
12:05 - 13:05
Room 4
ORAL PRESENTATION 1
Sep.10(Fri.)
13:05 - 14:05
Room 4
ORAL PRESENTATION 2
Sep.10(Fri.)
13:05 - 14:05
Room 5
PLENARY LECTURE 3
Sep.10(Fri.)
14:05 - 14:35
Room 1+2+3
Optimal medical therapy to inhibit coronary plaque Kenichi Hirata (Kobe University, Japan)
COFFEE BREAK
Sep.10(Fri.)
14:35 - 14:45
All
SYMPOSIUM 6 TG metabolism & lipolysis
Sep.10(Fri.)
14:45 - 16:20
Room 1
14:45-15:08 Is remnant lipoprotein atherogenic? Ki Hoon Han (University of Ulsan, Korea)
15:08-15:31 New therapeutics based on TG metabolism Hye-Jin Yoo (Korea University, Korea)
15:31-15:54 Update on ANGPTL3 inhibition trials
15:54-16:20 Discussion
SYMPOSIUM 7 Imaging of atherosclerosis
Sep.10(Fri.)
14:45 - 16:20
Room 2
14:45-15:08 Latest target molecules in imaging early & late atherosclerosis Jin-Won Kim (Korea University, Korea)
15:08-15:31 Molecular imaging in atherosclerosis Jung-joon Min (Chonnam National University, Korea)
15:31-15:54 Update on invasive imaging of vulnerable plaque So-Yeon Choi (Ajou University, Korea)
15:54-16:20 Discussion
SYMPOSIUM 8 Role of endothelial cells & ROS in atherosclerosis
Sep.10(Fri.)
14:45 - 16:20
Room 3
14:45-15:08 Endothelial cell epigenetic factors regulating atherosclerosis Hanjoong Jo (Emory University, USA)
15:08-15:31 Update on endothelial cell as target of anti-atherosclerosis treatment Kyung-Sun Heo (Chungnam National University, Korea)
15:31-15:54 ROS regulation in vascular cells Goo Taeg Oh (Ewha Womans University, Korea)
15:54-16:20 Discussion
SYMPOSIUM 9 Korean Dietary Reference Intakes(KDRI) for chronic disease risk reduction
Sep.10(Fri.)
14:45 - 16:20
Room 4
14:45-15:08 Sodium dietary reference intakes based on CV disease Min-Jeong Shin (Korea University, Korea)
15:08-15:31 Importance of dietary fatty acids in CV disease Gwang-woong Go (Hanyang University, Korea)
15:31-15:54 Dietary sugars & atherosclerotic risk Ji Yeon Kim (Seoul National University of Science and Technology, Korea)
15:54-16:20 Discussion
SYMPOSIUM 10 Principles & limitation of current lipid-lowering therapy
Sep.10(Fri.)
16:20 - 17:55
Room 1
16:20-16:43 What is trend & common points of latest lipid-lowering therapy guidelines? Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)
16:43-17:06 Is current stratification of very-high risk group appropriate? Jong-Young Lee (Sungkyunkwan University, Korea)
17:06-17:29 Is current LDL-C target achievable? Sung Hee Choi (Seoul National University, Korea)
17:29-17:55 Discussion
SYMPOSIUM 11 Latest trend of lipid modifying strategies
Sep.10(Fri.)
16:20 - 17:55
Room 2
16:20-16:43 Optimal treatment & LDL-C target for intermediate/low risk population
16:43-17:06 Timing & candidate of combination treatment Sin-Gon Kim (Korea University, Korea)
17:06-17:29 Is it worth to adjust lipid-lowering therapy by ethinicity & how?
17:29-17:55 Discussion
SYMPOSIUM 12 Influence of metabolic dysfunction in atherosclerosis
Sep.10(Fri.)
16:20 - 17:55
Room 3
16:20-16:43 Mechanism of vascular complications in obesity & metabolic syndrome Soo Lim (Seoul National University, Korea)
16:43-17:06 Immunometabolic control in macrophages Ichiro Manabe (Chiba University, Japan)
17:06-17:29 FABP as therapeutic target in ASCVD
17:29-17:55 Discussion
SYMPOSIUM 13 New techniques in basic atherosclerosis research
Sep.10(Fri.)
16:20 - 17:55
Room 4
16:20-16:43 Single cell techniques in atherosclerosis & dyslipidemia
16:43-17:06 Metabolomics in atherosclerosis & lipid metabolism Do Yup Lee (Seoul National University, Korea)
17:06-17:29 Proteomic studies in atherosclerotic cardiovascular disease Kyung-Gon Kim (University of Ulsan, Korea)
17:29-17:55 Discussion
DINNER
Sep.10(Fri.)
18:00 -
All
Organized by KSoLA

The Korean Society of Lipid and Atherosclerosis

No.707, Mapoacro Tower, 68 Mapo-daero, Mapo-gu, Seoul 04168, Korea
  • Business Registration Number : 110-82-60956
  • Chairman : Donghoon Choi

Secretariat of ICoLA 2021 │ People & Value, Inc.

#A-1108, Doosan The Land Park, 161-8, Magokjungang-ro, Gangseo-gu, Seoul, Republic of Korea

Copyrights 2021 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.